Warning: getimagesize(https://magazine.pharmamkt.net/wp-content/uploads/2020/09/logo-group.jpg): failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /home/luciamun/public_html/magazine/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 792

The largest community of pharma leaders

Otsuka, Janssen & IQVIA discuss how collect deeper patient insights for stronger patient outcomes

Dear Colleague

Patient insights are crucial. They are the key to the creation of successful, targeted programmes and new service offerings. They dictate the delivery of successful outcomes. But if we’re to gain deeper, richer insights, we must construct frameworks that help more patients articulate their value-drivers and hit on critical touchpoints.
At eyeforpharma, they’ve brought global leaders from Otsuka, Janssen, IQVIA & patient advocate Teresa Ferreiro together for a webinar on how to gather deeper patient insights that lead to targeted, personalised services, and ultimately, stronger patient outcomes.
  • Why designing frameworks with the patient in mind is insufficient: Work with patients from the beginning to ensure you collect comprehensive and pertinent insights
  • How to build your business case: Use insights to outline the commercial imperative of new services
  • It’s not just patients: When and how to engage HCPs and carers to gather a holistic view on how programmes can best operate
Join eyeforpharma on November 6 at 2pm London / 3pm Paris / 9am NY. Sign up for free here.
If you can’t make it, still sign-up and you’ll get the recording automatically to your inbox afterwards.
If you have any questions about this webinar, please contact Matt Atkinson, Head of Patient Initiatives, at eyeforpharma on matkinson@eyeforpharma.com.
I hope you find these useful!
 
Best regards,
Lucy Muñiz MD
Editor The Pharmaceutical Marketing Group
http://magazine.pharmamkt.net 
0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

Asana BioSciences to Present Positive Results from Phase 2b Study of Oral JAK/SYK Inhibitor Gusacitinib in Patients with Chronic Hand Eczema in the Late-Breaking...

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences’ Oral Gusacitinib (ASN002) demonstrates rapid and significant...

Aptinyx Announces Proposed Public Offering of Common Stock

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing...

Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging...

AppliedVR Receives FDA Breakthrough Device Designation to Treat Pain with Digital Therapeutic

LOS ANGELES--(BUSINESS WIRE)-- #chronicpain--AppliedVR, a pioneer advancing the next generation of...

After Meeting with FDA, Guided Therapeutics to Start Study in Support of its Application for FDA Approval

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- #FDA--After Meeting with FDA, Guided Therapeutics to...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.